Keeping Current CME podcast

Chronic Myeloid Leukemia: A 2025 Update on Novel Targets and Recent Clinical Data

0:00
30:42
Rewind 15 seconds
Fast Forward 15 seconds

How do STAMP inhibitors differ from ATP-competitive tyrosine kinase inhibitors (TKIs) when treating chronic myeloid leukemia (CML)?

Credit available for this activity expires: 03/13/26
Earn Credit / Learning Objectives & Disclosures: https://www.medscape.org/viewarticle/chronic-myeloid-leukemia-2025-update-novel-targets-and-2025a10005pm?ecd=bdc_podcast_libsyn_mscpedu

More episodes from "Keeping Current CME"